NZ503662A - Crystalline polymorph of (-)-4-[4-[4-[4-[[(2R-cis)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)furan-3-yl]-methoxy]phenyl]-1-piperazinyl]phenyl-2,4-dihydro-2-[(S)-1-ethyl-2(S)-hydroxylpropyl]-3H-1,2,4-triazol-3-one and its use as a fungicide - Google Patents

Crystalline polymorph of (-)-4-[4-[4-[4-[[(2R-cis)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)furan-3-yl]-methoxy]phenyl]-1-piperazinyl]phenyl-2,4-dihydro-2-[(S)-1-ethyl-2(S)-hydroxylpropyl]-3H-1,2,4-triazol-3-one and its use as a fungicide

Info

Publication number
NZ503662A
NZ503662A NZ503662A NZ50366298A NZ503662A NZ 503662 A NZ503662 A NZ 503662A NZ 503662 A NZ503662 A NZ 503662A NZ 50366298 A NZ50366298 A NZ 50366298A NZ 503662 A NZ503662 A NZ 503662A
Authority
NZ
New Zealand
Prior art keywords
triazol
phenyl
hydroxylpropyl
difluorophenyl
ylmethyl
Prior art date
Application number
NZ503662A
Other languages
English (en)
Inventor
William Leong
Anantha R Sudhakar
David R Andrews
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NZ503662A publication Critical patent/NZ503662A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ503662A 1997-10-07 1998-10-05 Crystalline polymorph of (-)-4-[4-[4-[4-[[(2R-cis)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)furan-3-yl]-methoxy]phenyl]-1-piperazinyl]phenyl-2,4-dihydro-2-[(S)-1-ethyl-2(S)-hydroxylpropyl]-3H-1,2,4-triazol-3-one and its use as a fungicide NZ503662A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07
PCT/US1998/020476 WO1999018097A1 (en) 1997-10-07 1998-10-05 Crystalline antifungal polymorph

Publications (1)

Publication Number Publication Date
NZ503662A true NZ503662A (en) 2002-10-25

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ503662A NZ503662A (en) 1997-10-07 1998-10-05 Crystalline polymorph of (-)-4-[4-[4-[4-[[(2R-cis)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)furan-3-yl]-methoxy]phenyl]-1-piperazinyl]phenyl-2,4-dihydro-2-[(S)-1-ethyl-2(S)-hydroxylpropyl]-3H-1,2,4-triazol-3-one and its use as a fungicide

Country Status (30)

Country Link
EP (1) EP1021439B1 (enExample)
JP (4) JP2001519346A (enExample)
KR (1) KR100626109B1 (enExample)
CN (1) CN1125067C (enExample)
AR (1) AR015947A1 (enExample)
AT (1) ATE263163T1 (enExample)
AU (1) AU759982B2 (enExample)
BR (1) BR9812866A (enExample)
CA (1) CA2305803C (enExample)
CO (1) CO4970829A1 (enExample)
CZ (1) CZ299835B6 (enExample)
DE (1) DE69822859T2 (enExample)
DK (1) DK1021439T3 (enExample)
ES (1) ES2217594T3 (enExample)
HU (1) HU225233B1 (enExample)
ID (1) ID29290A (enExample)
IL (1) IL135331A (enExample)
IN (1) IN1998CH02232A (enExample)
MX (1) MX225999B (enExample)
MY (1) MY130126A (enExample)
NO (1) NO318827B1 (enExample)
NZ (1) NZ503662A (enExample)
PE (1) PE120499A1 (enExample)
PH (1) PH11998002606B1 (enExample)
PL (1) PL189317B1 (enExample)
PT (1) PT1021439E (enExample)
SK (1) SK285190B6 (enExample)
TW (1) TW589310B (enExample)
WO (1) WO1999018097A1 (enExample)
ZA (1) ZA989063B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) * 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2451805A1 (en) 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole
US9199919B2 (en) 2010-05-19 2015-12-01 Sandoz Ag Process for the preparation of chiral hydrazides
RU2580318C2 (ru) 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
EP2571871B1 (en) * 2010-05-19 2017-06-21 Sandoz AG Process for the preparation of chiral triazolones
CN108329303A (zh) 2011-06-16 2018-07-27 桑多斯股份公司 制备手性化合物的方法
US9102664B2 (en) 2011-09-19 2015-08-11 Msn Laboratories Private Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
MX370849B (es) * 2013-07-25 2020-01-08 Sandoz Ag Proceso mejorado para preparar la forma cristalina iv del posaconazol.
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
KR102331856B1 (ko) 2014-10-21 2021-11-29 다케다 야쿠힌 고교 가부시키가이샤 결정 형태의 5-클로로-n4-[2-(디메틸포스포릴)페닐]-n2-{2-메톡시-4-[4-(4-메틸피페라진-1-일)피페리딘-1-일]피리미딘-2,4-디아민
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
WO2017025292A1 (en) 2015-08-08 2017-02-16 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant formulation containing posaconazole
EA039213B1 (ru) 2015-12-24 2021-12-17 Такеда Фармасьютикал Компани Лимитед Сокристалл, способ его получения и лекарственное средство, содержащее сокристалл
EP3925601B1 (en) 2016-02-26 2024-07-17 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
AU2022324717A1 (en) 2021-11-25 2024-06-13 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
PL181193B1 (pl) * 1993-12-21 2001-06-29 Schering Corp Nowe pochodne tetrahydrofuranowe o działaniu przeciwgrzybicznym, kompozycja farmaceutyczna do leczenia infekcji grzybiczych oraz sposób wytwarzania tych związków
NZ278882A (en) * 1994-01-24 1997-06-24 Janssen Pharmaceutica Nv Piperazine-containing azole antifungal compounds
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
SK27097A3 (en) * 1995-06-02 1997-09-10 Schering Corp Tetrahydrofuran antifungals

Also Published As

Publication number Publication date
ES2217594T3 (es) 2004-11-01
HU225233B1 (en) 2006-08-28
ATE263163T1 (de) 2004-04-15
KR100626109B1 (ko) 2006-09-20
SK285190B6 (sk) 2006-08-03
ZA989063B (en) 1999-04-06
HUP0004899A2 (hu) 2002-02-28
NO318827B1 (no) 2005-05-09
CZ20001264A3 (cs) 2000-08-16
PL339659A1 (en) 2001-01-02
IL135331A0 (en) 2001-05-20
CN1281449A (zh) 2001-01-24
CA2305803C (en) 2009-12-22
PH11998002606B1 (en) 2006-08-10
PL189317B1 (pl) 2005-07-29
CN1125067C (zh) 2003-10-22
DE69822859T2 (de) 2005-01-27
KR20010030959A (ko) 2001-04-16
WO1999018097A1 (en) 1999-04-15
TW589310B (en) 2004-06-01
PE120499A1 (es) 1999-12-04
AR015947A1 (es) 2001-05-30
NO20001779L (no) 2000-06-06
HK1029588A1 (en) 2001-04-06
CA2305803A1 (en) 1999-04-15
SK5122000A3 (en) 2000-09-12
AU9780398A (en) 1999-04-27
MX225999B (es) 2005-02-02
HUP0004899A3 (en) 2002-03-28
DK1021439T3 (da) 2004-05-10
BR9812866A (pt) 2000-08-08
CZ299835B6 (cs) 2008-12-10
IN1998CH02232A (enExample) 2005-03-04
JP2001519346A (ja) 2001-10-23
EP1021439A1 (en) 2000-07-26
MY130126A (en) 2007-06-29
PT1021439E (pt) 2004-07-30
JP2008106075A (ja) 2008-05-08
JP2012153730A (ja) 2012-08-16
AU759982B2 (en) 2003-05-01
NO20001779D0 (no) 2000-04-06
EP1021439B1 (en) 2004-03-31
DE69822859D1 (de) 2004-05-06
MXPA00003404A (es) 2000-11-01
CO4970829A1 (es) 2000-11-07
JP2012153729A (ja) 2012-08-16
ID29290A (id) 2001-08-16
IL135331A (en) 2005-08-31

Similar Documents

Publication Publication Date Title
MY130126A (en) Crystalline antifungal polymorph
JP2001519346A5 (enExample)
IL88901A (en) Substituted 1,2,3-triazole, 1,2,4-triazole, pyrazole and pyrrole derivatives, their preparation and pharmaceutical compositions containing them
CA2027876A1 (en) Use of substituted imidazoles
IE821285L (en) Triazole antifungal agents
NO986087L (no) Oralt preparat omfattende en antifungal triazolforbindelse
LU88778I2 (fr) Anastrozole optionellement sous forme d'un sel d'addition d'acide pharmaceutiquement acceptable (Arimidex (R))
KR970705558A (ko) 항진균 활성을 갖는 신규 피리미돈 유도체(new pyrimidone derivatives with antifungal activity)
DE3684431D1 (de) Derivate des ((4-(4-(4-phenyl-1-piperazinyl)phenoxymethyl)-1,3-dioxolan-2yl)methyl)-1h-imidazol und 1h-1,2,4-triazol.
HUT50333A (en) Process for producing pharmaceutical compositions comprising 1h-imidazoles and 1h-1,2,4-triazoles as active ingredient and process for producing the active ingredients
CA2371012A1 (en) 4-(1h-pyrrol-1-yl) imidazoles
NZ315184A (en) Use of fluconazole for inhibiting the growth of cancers and viral infections
RU97115290A (ru) Соединения азола, способ получения указанных соединений и их применение
IE832184L (en) Derivatives of imidazole and 1, 2, 4-triazole.
CA2255663A1 (en) Antifungal composition with enhanced bioavailability
IL70718A (en) 2-phenyl-1-(imidazo-2-yl or 1,2,4-triazol-3-yl or tetrazol-5-yl)-3-(1h-1,2,4-triazol-1-yl)propan-2-ol derivatives,their preparation and pharmaceutical compositions containing them
HU913882D0 (en) Fungicide preparation containing triazole derivatives
KR870010023A (ko) 이속사졸릴에탄올 유도체
EP0178682A3 (en) 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4-difluorophenyl)propane, antifungal composition containing it, and process for preparation of the compound and the composition
GB9318592D0 (en) Crystalline monohydrate of 2-(2,4-difluorophenyl),3-bis(1h-1,2,4-triazol-1-yl)-propan-2-ol
PT80628B (en) Process for preparing 4(5)-substituted imidazoles
EP0062236A3 (en) Fungicidal agent containing triazole derivatives, and process for combating fungi therewith
HUP9802763A2 (hu) Fitomikrobicid készítmények és alkalmazásuk
TH61733B (th) คริสตัลไลน์ แอนตีฟังกัล โพลีมอร์ฟ
TH51146A (th) คริสตัลไลน์ แอนตีฟังกัล โพลีมอร์ฟ

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired